Clinical Study of Tang Wang Prescription Intervene Diabetic Non-proliferative Retinopathy

Summary

This study include 384 Participants with diabetic non-proliferative retinopathy

Design Method: Randomized, double blind, placebo controlled and multicenter clinical study. Participants treatment for 48 weeks, and main aimed to evaluate the therapeutic effect of tang wang prescription improve degree of retinal microvascular disease of patients with diabetic non-proliferative retinopathy.

Conditions

• Diabetic Non-proliferative Retinopathy
• Type2 Diabetes

Interventions

DRUG

Tangwang prescription

A kind of Granule(Tangwang prescription) was composition by five Chinese herbal medicines, every bag has 4.87g granules.

DRUG

Placebo

Placebo is a simulated drug of tangwang prescription,included weight, appearance, colour, taste,smell and solubility.

Sponsors & Collaborators

• Guang'anmen Hospital of China Academy of Chinese Medical Sciences

  collaborator OTHER

• The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine

  collaborator OTHER

• Hubei Hospital of Traditional Chinese Medicine

  collaborator OTHER

• Zhengzhou City Hospital of Traditional Chinese Medicine

  collaborator OTHER

• Baodin City Hospital of Traditional Chinese Medicine

  collaborator UNKNOWN

• zi bo wanjie cancer hospital

  collaborator UNKNOWN

• Shijiazhuang City Hospital of Traditional Chinese Medicine

  collaborator UNKNOWN

• Zouping Country Hospital of Traditional Chinese Medicine

  collaborator UNKNOWN

• Fengmei Lian

  lead OTHER

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

30 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2017-02-28

Primary Completion

2019-05-31

Completion

2020-05-31